סימדקס 2.5 מגמל
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
LEVOSIMENDAN
Available from:
BIO-MED - J.R LTD, ISRAEL
ATC code:
C01CX08
Pharmaceutical form:
תרכיז להכנת תמיסה לאינפוזיה
Composition:
LEVOSIMENDAN 2.5 MG/ML
Administration route:
תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
ORION CORPORATION ORION PHARMA,FINLAND
Therapeutic group:
LEVOSIMENDAN
Therapeutic area:
LEVOSIMENDAN
Therapeutic indications:
Therapeutic indications: Short-term treatment of acutely decompensated severe chronic heart failure.Simdax should only be used as add-on therapy in situations where conventional therapy with e.g. diuretics, ACE-inhibitors and digitalis is not sufficient and where there is a need for inotropic support.
Authorization date:
2013-12-31
